Back to first-pass browser

First-pass extracted concept

protein arginine methyltransferases

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

PRMTs

Extracted Explainers

What the tool is doing

The abstract presents PRMTs as enzymes mediating protein arginine methylation and regulating tumor angiogenesis pathways including VEGFR-2 signaling.

Source 1DOIPubMed

What problem it solves

The source frames PRMT targeting as a way to suppress angiogenesis and reduce cancer progression in breast cancer-related contexts.

Source 1DOIPubMed

What it does not solve

The abstract does not establish that PRMT targeting alone is sufficient to overcome resistance or resolve toxicity concerns.

Source 1DOIPubMed

Evidence Snippets

Protein arginine methylation is an epigenetic modification ... mediated by protein arginine methyltransferases (PRMTs).
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1mechanistic effectsupports2025Source 1DOIPubMed

Inhibiting PRMT5 suppresses VEGF-induced vessel sprouting and impairs HIF-1α stability and VEGFR-2 phosphorylation in experimental models.

Quoted textsource-backed
For example, inhibiting PRMT5 suppresses VEGF-induced vessel sprouting in experimental models while impairing hypoxia-inducible factor 1-alpha (HIF-1α) stability and VEGFR-2 phosphorylation.
Claim 2mechanistic effectsupports2025Source 1DOIPubMed

PRMT1 and PRMT4 influence VEGF isoform expression, leading to increased angiogenesis.

Quoted textsource-backed
PRMT1 and PRMT4 similarly influence VEGF isoform expression, leading to increased angiogenesis.
Claim 3mechanistic rolesupports2025Source 1DOIPubMed

PRMT1, PRMT4, and PRMT5 activate distinct stages of angiogenesis.

Quoted textsource-backed
PRMT1, PRMT4, and PRMT5 activate distinct stages of angiogenesis.
Claim 4mechanistic rolesupports2025Source 1DOIPubMed

PRMTs regulate tumor angiogenesis pathways including VEGFR-2 signaling.

Quoted textsource-backed
PRMTs regulate various tumor angiogenesis pathways, including vascular endothelial growth factor receptor-2 (VEGFR-2) signaling.
Claim 5therapeutic effectsupports2025Source 1DOIPubMed

Targeting PRMTs in experimental models suppresses angiogenesis and reduces cancer progression.

Quoted textsource-backed
Targeting PRMTs in experimental models results in suppressed angiogenesis and reduced cancer progression.